VERACYTE, INC. — Director's Dealing 2021

Mar 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERACYTE, INC. (VCYT)
CIK: 0001384101
Period of Report: 2021-03-04

Reporting Person: Kennedy Giulia C (Chief Scientific & Med Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-04	Common Stock	M	5313	$9.05	Acquired	80082	Direct
2021-03-04	Common Stock	M	4407	$5.98	Acquired	84489	Direct
2021-03-04	Common Stock	M	3750	$20.21	Acquired	88239	Direct
2021-03-04	Common Stock	M	17500	$24.69	Acquired	105739	Direct
2021-03-04	Common Stock	S	20239	$47.1142	Disposed	85500	Direct
2021-03-04	Common Stock	S	8483	$48.2857	Disposed	77017	Direct
2021-03-04	Common Stock	S	2991	$49.2176	Disposed	74026	Direct
2021-03-04	Common Stock	S	2819	$50.3985	Disposed	71207	Direct
2021-03-04	Common Stock	S	8114	$51.3804	Disposed	63093	Direct
2021-03-04	Common Stock	S	5032	$52.3776	Disposed	58061	Direct
2021-03-04	Common Stock	S	2606	$53.4975	Disposed	55455	Direct
2021-03-04	Common Stock	S	1431	$54.724	Disposed	54024	Direct
2021-03-04	Common Stock	S	300	$55.49	Disposed	53724	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-04	Stock Option (right to buy)	$9.05	M	5313	Disposed	2027-03-02	Common Stock (5313.0)	Direct
2021-03-04	Stock Option (right to buy)	$5.98	M	4407	Disposed	2028-03-01	Common Stock (4407.0)	Direct
2021-03-04	Stock Option (right to buy)	$20.21	M	3750	Disposed	2029-02-27	Common Stock (3750.0)	Direct
2021-03-04	Stock Option (right to buy)	$24.69	M	17500	Disposed	2030-03-27	Common Stock (17500.0)	Direct

Footnotes

F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020.

F2: Represents weighted average sales price. Sale prices for the transactions range from $46.78 to $47.78. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

F3: Represents weighted average sales price. Sale prices for the transactions range from $47.80 to $48.80. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

F4: Represents weighted average sales price. Sale prices for the transactions range from $48.82 to $49.81. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

F5: Represents weighted average sales price. Sale prices for the transactions range from $49.87 to $50.87. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

F6: Represents weighted average sales price. Sale prices for the transactions range from $50.90 to $51.89. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

F7: Represents weighted average sales price. Sale prices for the transactions range from $51.94 to $52.93. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

F8: Represents weighted average sales price. Sale prices for the transactions range from $52.99 to $53.99. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

F9: Represents weighted average sales price. Sale prices for the transactions range from $54.11 to $55.10. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

F10: Represents weighted average sales price. Sale prices for the transactions range from $55.31 to $55.67. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

F11: The option is fully vested.

F12: The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.

F13: The option becomes exercisable as to 25% of the shares on February 28, 2020, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.

F14: The option becomes exercisable as to 25% of the shares on February 28, 2021, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.